AJMC October 8, 2024
Key Takeaways
- CMS actuaries predict moderate per capita health spending growth, initially slowed by the Inflation Reduction Act and Medicaid unwinding.
- Medicare drug price reforms will reduce spending in 2026, with prescription drug spending growing at 5.4% annually from 2026 to 2032.
- Out-of-pocket spending will rise, with Medicare benefit changes, including the elimination of the 5% coinsurance for catastrophic coverage.
- Health spending will grow faster than the economy, reaching 19.7% of GDP by 2032, with per capita expenditures increasing from $14,423 in 2023 to $21,927 by 2032.
CMS actuaries predict a moderate increase in per capita health spending over the next decade, with growth rates slowing in the near term due to factors like the Inflation Reduction Act...